• Prevention of Opportunistic Infections in Persons Infected with HIV (255kb)
  USPHS/IDSA - November, 2001
• Summary of Treatment Guidelines for Opportunistic Infections (255kb)
  USPHS/IDSA - November 2001
• Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents (1977kb)
  Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America - December 2004
• Treating Opportunistic Infections Among HIV-Exposed and Infected Children (370kb)
  Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America - December 2004
• Treatment of Tuberculosis Guidelines
  AIDSinfo, US Dept of Health and Human Services
• TB Treatment Guidelines (267kb)
  WHO-2002

• Cryptosporidiosis(Crypto)
• Cytomegalovirus (CMV)
• Hepatitis C
• Mycobacterium Avium Complex (MAC)
• Pneumocystis carinii (PCP)
• Toxoplasmosis (Toxo)
• Tuberculosis

• TB/HIV - A Clinical Manual (727kb)
  WHO - 2004
  
• HIV Web Study on Opportunistic Infections
  University of Washington – Northwest AIDS Education and Training Center
• Advance Management of HIV-related Opportunistic Infections (657kb)
  Christopher Mathews, M.D, UCSD Owen Clinic, HRSA Global AIDS Programme
  November 2003

ARV Recommendations

• Rifampin (149kb)
  CDC Recommendations for Co-administering Protease Inhibitors and NonNucleoside Reverse Transcriptase Inhibitors with Rifampin - January 2004
• Rifabutin (161kb)
  CDC Recommendations for Co-administering Protease Inhibitors and NonNucleoside Reverse Transcriptase Inhibitors with Rifabutin - January 2004